UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in TVTX — Travere Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in TVTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,087,922
+$4,016,914 QoQ
Shares Held
142,368
+3.9% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 315 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. TVTX ranks #46 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in TVTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,087,922 | 142,368 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,071,008 | 137,025 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,251,484 | 215,951 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,487,653 | 145,927 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,594,241 | 445,557 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,193,418 | 66,597 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $2,815,121 | 161,603 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,282,815 | 163,175 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,469,313 | 178,749 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $801,684 | 103,980 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $893,828 | 99,425 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $888,857 | 99,425 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,360,048 | 88,545 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $1,991,374 | 88,545 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,337,043 | 63,578 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,538,174 | 62,426 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,603,175 | 66,165 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,731,252 | 67,181 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,961,353 | 63,188 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,255,543 | 51,775 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $781,350 | 53,554 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,233,143 | 49,385 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,054,359 | 38,685 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 RTRX | — | 38,685 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 RTRX | — | 33,715 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 RTRX | — | 30,260 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||